Jorge I. Arango
University of Texas Health Science Center at San Antonio
6 Papers
59 Citations
Jorge I. Arango is an academic researcher from University of Texas Health Science Center at San Antonio. The author has contributed to research in topics: Mucositis & Transplantation. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
Jorge I. Arango,A. Restrepo,D. L. Schneider,N. S. Callander,N. S. Callander,J. L. Ochoa-Bayona,J. L. Ochoa-Bayona,Marcos I. Restrepo,Marcos I. Restrepo,Patrick T. Bradshaw,Jan E. Patterson,Jan E. Patterson,Cesar O. Freytes,Cesar O. Freytes +13 more
TL;DR: The incidence of C. difficile-associated diarrhea (CDAD) 1 week before and 30 days after APBSCT, and to identify risk factors for the development of CDAD including diagnosis, was determined.
70
Computed tomography grading systems poorly predict the need for intervention after spleen and liver injuries.
Stephen M. Cohn,Jorge I. Arango,John G. Myers,Peter P. Lopez,Rachelle B. Jonas,Lindsay L. Waite,Michael G. Corneille,Ronald M. Stewart,Daniel L. Dent +8 more
TL;DR: The overall sensitivity of all grading systems in predicting the need for surgery or angioembolization of the spleen or liver was poor; the specificity seemed to be fairly good; the strength of agreement for the various scoring systems was only moderate.
42
Diaphragmatic injuries: what has changed over a 20-year period?
Peter P. Lopez,Jorge I. Arango,Theresa M. Gallup,Stephen M. Cohn,John G. Myers,Michael G. Corneille,Ronald M. Stewart,Daniel L. Dent +7 more
TL;DR: The data suggests that over the last 20 years, the increase in mortality associated with traumatic diaphragmatic injury is primarily related to an increase in the proportion of patients with blunt trauma as a cause of their diaphRAGmatic injury and associated injuries.
26
Oral Mucositis Measured by the Oral Mucositis Assessment Scale (OMAS), but Not by the World Health Organization (WHO) Scoring System, Correlates with Nutritional Changes after Autologous Peripheral Blood Stem Cell Transplantation.
Juan J. Toro,Jorge I. Arango,Steven D. Westbrook,Pamela S. Jewell,Lee Shuko,Jose L. Ochoa-Bayona,Cesar O. Freytes +6 more
TL;DR: Oral mucositis measured by the OMAS, but not by the WHO scoring system, correlates with nutritional changes after APSCT in patients with lymphoid malignancies and decrease of the nutritional level in the NSCS correlated with adverse clinical outcome.
1
Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
Cesar O. Freytes,Voravit Ratanatharathorn,Charles W. Taylor,Camille N. Abboud,Nancy Chesser,Alejandro Restrepo,Jorge I. Arango,Daniel Odenheimer +7 more
TL;DR: Repifermin given before and after auto-HSCT seems to be active in reducing mucositis, but a larger trial will be necessary to determine the efficacy of repifermin with this dose schedule.